STOCK TITAN

Opaleye discloses 9.5% Alpha Cognition (ACOG) stake in Schedule 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Alpha Cognition Inc. received a Schedule 13G reporting a significant shareholder position by Opaleye-related entities. Opaleye Management Inc., Opaleye, L.P., and James Silverman report beneficial ownership of 2,070,784 shares of Alpha Cognition common stock, representing 9.52% of the class as of 12/31/2025.

Most of the position, 2,015,784 shares or 9.27% of the class, is held by Opaleye, L.P. The filer reports shared voting and shared dispositive power over 2,070,784 shares and no sole power. The reporting persons certify the holdings are not for the purpose of changing or influencing control of the company.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Based on 21,742,104 Common Shares outstanding as reported by Alpha Cognition, Inc. in its Form 10-Q filed with the SEC on November 13, 2025.


SCHEDULE 13G





SCHEDULE 13G



Opaleye Management Inc.
Signature:/s/ James Silverman
Name/Title:President
Date:02/06/2026
Opaleye, L.P.
Signature:/s/ James Silverman
Name/Title:General Partner
Date:02/06/2026
James Silverman
Signature:/s/ James Silverman
Name/Title:Individually
Date:02/06/2026

Comments accompanying signature: Exhibit 99.1 Joint Filing Agreement by and among the reporting persons

FAQ

What stake in Alpha Cognition (ACOG) did Opaleye report on this Schedule 13G?

Opaleye-related entities reported beneficial ownership of 2,070,784 Alpha Cognition common shares, representing 9.52% of the outstanding class as of 12/31/2025. This makes them a significant shareholder under U.S. securities rules requiring Schedule 13G disclosure.

Who are the reporting persons on the Alpha Cognition (ACOG) Schedule 13G?

The filing lists Opaleye Management Inc. (the investment adviser), Opaleye, L.P. (the fund), and James Silverman. The shares are directly held by Opaleye, L.P., while Opaleye Management advises the fund and James Silverman exercises control over the adviser.

How many Alpha Cognition (ACOG) shares are held directly by Opaleye, L.P.?

Opaleye, L.P. is reported as directly holding 2,015,784 Alpha Cognition common shares, equal to 9.27% of the class. The percentage is based on 21,742,104 common shares outstanding, as reported by Alpha Cognition in a prior Form 10-Q.

What voting and dispositive powers are reported over Alpha Cognition (ACOG) shares?

The reporting persons state they have shared voting power and shared dispositive power over 2,070,784 shares, and no sole voting or dispositive power. This means decisions on voting and selling these shares are made jointly, not individually.

Does the Opaleye Schedule 13G indicate an attempt to control Alpha Cognition (ACOG)?

No. The reporting persons specifically certify the securities were not acquired and are not held to change or influence control of Alpha Cognition. They also note the filing should not be construed as an admission of beneficial ownership under Section 13.

What key date is associated with Opaleye’s Alpha Cognition (ACOG) holdings in this Schedule 13G?

The Schedule 13G identifies 12/31/2025 as the date of the event requiring the filing. Ownership percentages, including the 9.52% stake, are calculated as of that date using Alpha Cognition’s then-reported outstanding share count.

Alpha Cognition

NASDAQ:ACOG

ACOG Rankings

ACOG Latest News

ACOG Latest SEC Filings

ACOG Stock Data

127.19M
19.26M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
Canada
VANCOUVER